A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans

Abstract

Genome-wide association studies have implicated the CHRNA5-CHRNA3-CHRNB4 gene cluster in risk for heavy smoking and several smoking-related disorders. The heavy smoking risk allele might reduce the aversive effects of nicotine, but this hypothesis has not been tested in humans. We evaluated the effects of a candidate causal variant in CHRNA5, rs16969968, on the acute response to nicotine in European American (EA) and African American (AA) smokers (n=192; 50% AA; 73% male). Following overnight abstinence from nicotine, participants completed a protocol that included an intravenous (IV) dose of saline and two escalating IV doses of nicotine. The outcomes evaluated were the aversive, pleasurable, and stimulatory ratings of nicotine's effects, cardiovascular reactivity to nicotine, withdrawal severity, and cognitive performance before and after the nicotine administration session. The heavy smoking risk allele (rs16969968*A; frequency=28% (EA) and 6% (AA)) was associated with lower ratings of aversive effects (P<5 × 10(-8)) with marked specificity. This effect was evident in EA and AA subjects analyzed as separate groups and was most robust at the highest nicotine dose. Rs16969968*A was also associated with greater improvement on a measure of cognitive control (Stroop Task) following nicotine administration. These findings support differential aversive response to nicotine as one likely mechanism for the association of CHRNA5-CHRNA3-CHRNB4 with heavy smoking.

Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects

“…Items were used to calculate three factors: Feel Good (mean of “feel good drug effects”, “want more drug” and “like the drug”), Negative (mean of “anxious”, “feel down”, “feel bad drug effects”), and Stimulatory (mean of “stimulated”, “high”, and “feel drug strength”), with one item (“sedated”) not included in any factor [33]. …”

Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women

“…We chose these variants on the basis of numerous GWAS (Gelernter et al, 2014;Xu et al, 2015) and candidate-locus studies (Sherva et al, 2010;Hart et al, 2015;Jensen et al, 2015), and a recent meta-analysis of genetic studies of nicotine and alcohol traits (Buhler et al, 2015) and GWAS performed previously in different population groups (David et al, 2012;Gelernter et al, 2014).…”

Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics

“…Other variants in cholinergic nicotinic receptor genes have also been identified (e.g., Saccone et al, 2010), and these discoveries have spurred functional, neuroimaging, and pharmacogenetic studies (e.g., Fowler et al, 2011;Jensen et al, 2015). Variants in other genes have been sporadically implicated for a variety of substance use phenotypes, albeit with smaller effects sizes and less robustness (Agrawal et al, 2012).…”